CUSIP 09058V103COMBCRXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
271 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 22.27M | $173.73M | +482.5K | Added |
| 2 | Blackrock, Inc. | 21.14M | $164.87M | −108.1K | Reduced |
| 3 | Ra Capital Management, L.P. | 15.83M | $123.45M | +15.83M | New |
| 4 | Deerfield Management Company, L.P. | 14.34M | $111.86M |
| +2.17M |
| Added |
| 5 | State Street Corp | 11.07M | $86.37M | +1.27M | Added |
| 6 | Kynam Capital Management, LP | 9.37M | $73.06M | −23.7K | Reduced |
| 7 | Janus Henderson Group PLC | 7.40M | $57.79M | +7.31M | Added |
| 8 | Ubs Group AG | 5.26M | $41.06M | −703.8K | Reduced |
| 9 | Geode Capital Management, LLC | 5.05M | $39.43M | +1.5K | Added |
| 10 | Two Sigma Investments, LP | 4.52M | $35.22M | +95.7K | Added |
See every fund holding Biocryst Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders